Stocksigma LogoStocksigma Logo

Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Changes

Tavexia Lifecare's board approved evaluating an acquisition of up to 60% equity in unlisted Meyonex Pharmaceuticals (paid-up capital: Rs 13.99 crore)

Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Changes

Sattva Sukun Lifecare Ltd 路 Outcome 路 08 Sept 2026, 12:50 am

Tavexia Lifecare Board Approves Meyonex Acquisition Proposal and Auditor Changes Tavexia Lifecare's board approved evaluating an acquisition of up to 60% equity in unlisted Meyonex Pharmaceuticals (paid-up capital: Rs 13.99 crore), authorizing directors to conduct due diligence, valuation, and negotiations. The board accepted the resignation of statutory auditor M/s SSRV & Associates effective 7th Sep'26 and approved the appointment of M/s DEVAM & Associates LLP for a five-year term (FY27 to FY31), subject to shareholder approval. Additionally, the board re-appointed Khushboo Vasudev as Independent Director for five years from 31st Dec'26 and scheduled the 46th AGM.

Original exchange filing (PDF)

More announcements from Sattva Sukun Lifecare Ltd

All Sattva Sukun Lifecare Ltd announcements